A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
These boosters are recommended five years after the first meningitis vaccination and then every five years thereafter if vaccinated after age 7. If vaccinated between ages 2 and 7, the first booster should be given three years after the initial vaccine and then every five years.or many years, the meningitis vaccine used for teens was the MPSV4, or polysaccharide meningococcal vaccine. A new meningitis vaccine, the MCV4, or meningococcal conjugate vaccine, was approved in 2005.